DOM SPARK DEI Lecture with Wake Forest’s Dr. Ruben Mesa

The Department of Medicine at the University of Arizona College of Medicine – Tucson presents:

Topic: “Diverse Cancer Clinical Trials: Good Care – Good Science”
Ruben A. Mesa, MD, FACP

This Spark Lecture is eligible for 1 DEI credit. It is being delivered virtually. A hyperlink and QR code to download the form to apply for the credit will be displayed at the start and end of the presentation.

Thursday, Oct. 3, 2024 | Noon-1 p.m. (3-4 p.m. EST)

LIVESTREAM LINK!

Presenter: Dr. Ruben Mesa is senior vice president of Atrium Health as well as president and executive director of the Atrium Health Wake Forest Baptist Comprehensive Cancer Center, which has two locations, one in Charlotte and the other in Winston-Salem, North Carolina. He is also vice dean for cancer programs and the Charles L. Spurr, MD, Professor of Internal Medicine at Wake Forest University School of Medicine. In these roles, Dr. Mesa oversees all efforts related to cancer practice, research and education across the Atrium Health system. He is an international expert in hematologic cancers who has dedicated his life's work to research and drug development for myeloproliferative neoplasms (MPNs), a group of chronic leukemias that can cause difficult symptoms, bone marrow problems, acute leukemia and premature death. He has over 800 lifetime medical publications, with more than 400 peer-reviewed manuscripts, 15 book chapters and 2 edited books. He is frequently invited to speak on MPNs with over 600 such lectures and visiting professorships, nationally and internationally.

READ MORE

■ Flyer for this event:  dom_spark_dei_lecture_10.03.24_mesa_flyer_v3.pdf

Department of Medicine SPARK DEI Lecture Series

Accreditation Statement: The University of Arizona College of Medicine – Tucson is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The college’s Office of Diversity, Equity & Inclusion designates this live activity for a maximum of 1 DEI credit. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Statement: All Faculty, CME Planning Committee Members, and the CME Office Reviewers have disclosed that they have no financial relationships with ineligible companies that would constitute a conflict of interest concerning this CME activity.

Learning Objectives:

1. Understand the numerous contributors to lack of diversity historically on cancer clinical trials
2. Learn various approaches being utilized to try to have clinical trials more closely match patient populations
3. Understand the implications of new health policy changes regarding registration trials overseen by the FDA

For questions or accommodations that may be necessary, contact the Office of the Chair, 520-626-6349 at least three days in advance of event.